Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-023573
Date:2021-03-26
Issuer: IRONWOOD PHARMACEUTICALS INC (IRWD)
Original Submission Date:

Reporting Person:

MCCOURT THOMAS A
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300 BOSTON, MA 02110

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
CLASS A COMMON STOCK 2021-03-26 A 96,638 a $0.00 568,215 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the restricted stock units, granted as a retention award, vest as to 50% of the shares of class a common stock on each of may 19, 2022 and may 18, 2023.
WhaleWisdom Logo

Elevate your investments